Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study.
Al Sulaiman K, Aljuhani O, Badreldin HA, Korayem GB, Alenazi AA, Alharbi AH, Alghamdi A, Alhubaishi A, Altebainawi AF, Bosaeed M, Alotaibi R, Alawad A, Alnajjar N, Bin Saleh K, Sait WA, Alsohimi S, Alanizy MM, Almuqbil SA, Al Sulaihim I, Vishwakarma R, Alalawi M, Alhassan F, Alghnam S. Al Sulaiman K, et al. Among authors: korayem gb. BMC Infect Dis. 2023 Feb 6;23(1):75. doi: 10.1186/s12879-023-08010-8. BMC Infect Dis. 2023. PMID: 36747136 Free PMC article.
Single versus multiple doses of Tocilizumab in critically ill patients with coronavirus disease 2019 (COVID-19): A two-center, retrospective cohort study.
Al Sulaiman K, Aljuhani O, Bin Salah K, Korayem GB, Eljaaly K, Al Essa M, Kharbosh A, Al Harbi F, Abuzaid M, Al Bilal S, Almagthali A, Alsohemi S, Alshabasy A, Noureldeen H, Aboudeif M, Alshehri A, Vishwakarma R. Al Sulaiman K, et al. Among authors: korayem gb. J Crit Care. 2021 Dec;66:44-51. doi: 10.1016/j.jcrc.2021.08.007. Epub 2021 Aug 23. J Crit Care. 2021. PMID: 34438133 Free PMC article.
Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study.
Aljuhani O, Al Sulaiman K, Alshabasy A, Eljaaly K, Al Shaya AI, Noureldeen H, Aboudeif M, Al Dosari B, Alkhalaf A, Korayem GB, Aleissa MM, Badreldin HA, Al Harbi S, Alhammad A, Vishwakarma R. Aljuhani O, et al. Among authors: korayem gb. BMC Infect Dis. 2021 Nov 1;21(1):1127. doi: 10.1186/s12879-021-06813-1. BMC Infect Dis. 2021. PMID: 34724920 Free PMC article.
The Role of Inhaled Corticosteroids (ICS) in Critically Ill Patients With COVID-19: A Multicenter, Cohort Study.
Al Sulaiman K, Aljuhani O, Al Aamer K, Al Shaya O, Al Shaya A, Alsaeedi AS, Alhubaishi A, Altebainawi AF, Al Harthi A, Albelwi S, Almutairi R, Alsubaie N, Alsallum A, Korayem GB, Alfahed A, Kensara R, Altebainawi EF, Alenezi RS, Alsulaiman T, Al Enazi H, Vishwakarma R, Al Dabbagh T, Bakhsh U, Al Ghamdi G. Al Sulaiman K, et al. Among authors: korayem gb. J Intensive Care Med. 2022 Feb;37(2):248-257. doi: 10.1177/08850666211053548. Epub 2021 Nov 10. J Intensive Care Med. 2022. PMID: 34757869
Clinical pharmacy definition, required education, training and practice in Saudi Arabia: A position statement by the Saudi society of clinical pharmacy.
Korayem GB, Badreldin HA, Eljaaly K, Aldemerdash A, Al-Suhaibani LK, Joharji H, Aljuhani O, Al-Omari BA, Almudaiheem HY, Alhifany AA, Alawagi M, Al-Mowaina SM, Al-Jazairi AS, Albekairy AM, Al-Jedai A. Korayem GB, et al. Saudi Pharm J. 2021 Nov;29(11):1343-1347. doi: 10.1016/j.jsps.2021.09.008. Epub 2021 Sep 21. Saudi Pharm J. 2021. PMID: 34819795 Free PMC article.
Comparison between standard Vs. Escalated dose venous thromboembolism (VTE) prophylaxis in critically ill patients with COVID-19: A two centers, observational study.
Aljuhani O, Al Sulaiman K, Hafiz A, Eljaaly K, Alharbi A, Algarni R, Al Homaid S, Kahtani K, Alsulaiman T, Vishwakarma R, Al Ghamdi G, Alalawi M, Korayem GB. Aljuhani O, et al. Among authors: korayem gb. Saudi Pharm J. 2022 Apr;30(4):398-406. doi: 10.1016/j.jsps.2022.01.022. Epub 2022 Feb 3. Saudi Pharm J. 2022. PMID: 35136364 Free PMC article.
Evaluation of Low-Dose Aspirin use among Critically Ill Patients with COVID-19: A Multicenter Propensity Score Matched Study.
Al Harthi AF, Aljuhani O, Korayem GB, Altebainawi AF, Alenezi RS, Al Harbi S, Gramish J, Kensara R, Hafidh A, Al Enazi H, Alawad A, Alotaibi R, Alshehri A, Alhuthaili O, Vishwakarma R, Bin Saleh K, Alsulaiman T, Alqahtani RA, Hussain S, Almazrou S, Al Sulaiman K. Al Harthi AF, et al. Among authors: korayem gb. J Intensive Care Med. 2022 Sep;37(9):1238-1249. doi: 10.1177/08850666221093229. Epub 2022 Apr 21. J Intensive Care Med. 2022. PMID: 35450493 Free PMC article.
Evaluation of Apixaban safety and effectiveness in morbidly obese patients with atrial fibrillation: a retrospective cohort study.
Al Sulaiman K, Badreldin HA, Korayem GB, Alenazi AA, Alsuwayyid F, Alrashidi A, Alhijris M, Almutairi F, Alharthi F, Vishwakarma R, Al Shaya O, Al Amri A, Tayyab S, Al Bekairy AM, Aljuhani O. Al Sulaiman K, et al. Among authors: korayem gb. Thromb J. 2022 May 2;20(1):25. doi: 10.1186/s12959-022-00379-x. Thromb J. 2022. PMID: 35501916 Free PMC article.
Evaluation of Apixaban in Patients With Antiphospholipid Syndrome: A Case Series and Review of Literature.
Al Sulaiman K, Hafiz A, Badreldin HA, Korayem GB, Alsuwayyid F, Alrashidi PharmD A, Alhijris M, Almutairi PharmD F, Alharthi F, Alghamdi S, Abu Alreesh A, Aljuhani O. Al Sulaiman K, et al. Among authors: korayem gb. J Investig Med High Impact Case Rep. 2022 Jan-Dec;10:23247096221099893. doi: 10.1177/23247096221099893. J Investig Med High Impact Case Rep. 2022. PMID: 35593449 Free PMC article. Review.
57 results